- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
The Human Cytomegalovirus Envelope Glycoprotein B market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Human Cytomegalovirus Envelope Glycoprotein B market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Infectious Disease accounting for % of the Human Cytomegalovirus Envelope Glycoprotein B global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While CSJ-148 segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Human Cytomegalovirus Envelope Glycoprotein B include Astellas Pharma Inc., Trellis Bioscience, Inc., Vakzine Projekt Management GmbH, VBI Vaccine Inc, and Vical Incorporated, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Human Cytomegalovirus Envelope Glycoprotein B market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
CSJ-148
CyMVectin
TRL-345
PPCM
Cytomegalovirus Vaccine
Others
Market segment by Application can be divided into
Infectious Disease
Oncology
Women's Health
Others
The key market players for global Human Cytomegalovirus Envelope Glycoprotein B market are listed below:
Astellas Pharma Inc.
Trellis Bioscience, Inc.
Vakzine Projekt Management GmbH
VBI Vaccine Inc
Vical Incorporated
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Cytomegalovirus Envelope Glycoprotein B product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Human Cytomegalovirus Envelope Glycoprotein B, with price, sales, revenue and global market share of Human Cytomegalovirus Envelope Glycoprotein B from 2019 to 2022.
Chapter 3, the Human Cytomegalovirus Envelope Glycoprotein B competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Cytomegalovirus Envelope Glycoprotein B breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Human Cytomegalovirus Envelope Glycoprotein B market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Human Cytomegalovirus Envelope Glycoprotein B.
Chapter 13, 14, and 15, to describe Human Cytomegalovirus Envelope Glycoprotein B sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Human Cytomegalovirus Envelope Glycoprotein B Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 CSJ-148
1.2.3 CyMVectin
1.2.4 TRL-345
1.2.5 PPCM
1.2.6 Cytomegalovirus Vaccine
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Infectious Disease
1.3.3 Oncology
1.3.4 Women's Health
1.3.5 Others
1.4 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size & Forecast
1.4.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Human Cytomegalovirus Envelope Glycoprotein B Sales in Volume (2017-2028)
1.4.3 Global Human Cytomegalovirus Envelope Glycoprotein B Price (2017-2028)
1.5 Global Human Cytomegalovirus Envelope Glycoprotein B Production Capacity Analysis
1.5.1 Global Human Cytomegalovirus Envelope Glycoprotein B Total Production Capacity (2017-2028)
1.5.2 Global Human Cytomegalovirus Envelope Glycoprotein B Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Human Cytomegalovirus Envelope Glycoprotein B Market Drivers
1.6.2 Human Cytomegalovirus Envelope Glycoprotein B Market Restraints
1.6.3 Human Cytomegalovirus Envelope Glycoprotein B Trends Analysis
2 Manufacturers Profiles
2.1 Astellas Pharma Inc.
2.1.1 Astellas Pharma Inc. Details
2.1.2 Astellas Pharma Inc. Major Business
2.1.3 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Product and Services
2.1.4 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Trellis Bioscience, Inc.
2.2.1 Trellis Bioscience, Inc. Details
2.2.2 Trellis Bioscience, Inc. Major Business
2.2.3 Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Product and Services
2.2.4 Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Vakzine Projekt Management GmbH
2.3.1 Vakzine Projekt Management GmbH Details
2.3.2 Vakzine Projekt Management GmbH Major Business
2.3.3 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Product and Services
2.3.4 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 VBI Vaccine Inc
2.4.1 VBI Vaccine Inc Details
2.4.2 VBI Vaccine Inc Major Business
2.4.3 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Product and Services
2.4.4 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Vical Incorporated
2.5.1 Vical Incorporated Details
2.5.2 Vical Incorporated Major Business
2.5.3 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Product and Services
2.5.4 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Human Cytomegalovirus Envelope Glycoprotein B Breakdown Data by Manufacturer
3.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Human Cytomegalovirus Envelope Glycoprotein B
3.4 Market Concentration Rate
3.4.1 Top 3 Human Cytomegalovirus Envelope Glycoprotein B Manufacturer Market Share in 2021
3.4.2 Top 6 Human Cytomegalovirus Envelope Glycoprotein B Manufacturer Market Share in 2021
3.5 Global Human Cytomegalovirus Envelope Glycoprotein B Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Human Cytomegalovirus Envelope Glycoprotein B Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size by Region
4.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales in Volume by Region (2017-2028)
4.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region (2017-2028)
4.2 North America Human Cytomegalovirus Envelope Glycoprotein B Revenue (2017-2028)
4.3 Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue (2017-2028)
4.4 Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Revenue (2017-2028)
4.5 South America Human Cytomegalovirus Envelope Glycoprotein B Revenue (2017-2028)
4.6 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales in Volume by Type (2017-2028)
5.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2017-2028)
5.3 Global Human Cytomegalovirus Envelope Glycoprotein B Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales in Volume by Application (2017-2028)
6.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2017-2028)
6.3 Global Human Cytomegalovirus Envelope Glycoprotein B Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2017-2028)
7.2 North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2017-2028)
7.3 North America Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country
7.3.1 North America Human Cytomegalovirus Envelope Glycoprotein B Sales in Volume by Country (2017-2028)
7.3.2 North America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2017-2028)
8.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2017-2028)
8.3 Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country
8.3.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales in Volume by Country (2017-2028)
8.3.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2017-2028)
9.2 Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2017-2028)
9.3 Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Size by Region
9.3.1 Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2017-2028)
10.2 South America Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2017-2028)
10.3 South America Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country
10.3.1 South America Human Cytomegalovirus Envelope Glycoprotein B Sales in Volume by Country (2017-2028)
10.3.2 South America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2017-2028)
11.2 Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2017-2028)
11.3 Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country
11.3.1 Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Human Cytomegalovirus Envelope Glycoprotein B and Key Manufacturers
12.2 Manufacturing Costs Percentage of Human Cytomegalovirus Envelope Glycoprotein B
12.3 Human Cytomegalovirus Envelope Glycoprotein B Production Process
12.4 Human Cytomegalovirus Envelope Glycoprotein B Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Human Cytomegalovirus Envelope Glycoprotein B Typical Distributors
13.3 Human Cytomegalovirus Envelope Glycoprotein B Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Astellas Pharma Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Astellas Pharma Inc. Major Business
Table 5. Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Product and Services
Table 6. Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Trellis Bioscience, Inc. Basic Information, Manufacturing Base and Competitors
Table 8. Trellis Bioscience, Inc. Major Business
Table 9. Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Product and Services
Table 10. Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Vakzine Projekt Management GmbH Basic Information, Manufacturing Base and Competitors
Table 12. Vakzine Projekt Management GmbH Major Business
Table 13. Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Product and Services
Table 14. Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. VBI Vaccine Inc Basic Information, Manufacturing Base and Competitors
Table 16. VBI Vaccine Inc Major Business
Table 17. VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Product and Services
Table 18. VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Vical Incorporated Basic Information, Manufacturing Base and Competitors
Table 20. Vical Incorporated Major Business
Table 21. Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Product and Services
Table 22. Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Pcs)
Table 24. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 25. Market Position of Manufacturers in Human Cytomegalovirus Envelope Glycoprotein B, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 26. Global Human Cytomegalovirus Envelope Glycoprotein B Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 27. Head Office and Human Cytomegalovirus Envelope Glycoprotein B Production Site of Key Manufacturer
Table 28. Human Cytomegalovirus Envelope Glycoprotein B New Entrant and Capacity Expansion Plans
Table 29. Human Cytomegalovirus Envelope Glycoprotein B Mergers & Acquisitions in the Past Five Years
Table 30. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2017-2022) & (K Pcs)
Table 31. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2023-2028) & (K Pcs)
Table 32. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region (2017-2022) & (USD Million)
Table 33. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region (2023-2028) & (USD Million)
Table 34. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2017-2022) & (K Pcs)
Table 35. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2023-2028) & (K Pcs)
Table 36. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2017-2022) & (USD Million)
Table 37. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2023-2028) & (USD Million)
Table 38. Global Human Cytomegalovirus Envelope Glycoprotein B Price by Type (2017-2022) & (USD/Pcs)
Table 39. Global Human Cytomegalovirus Envelope Glycoprotein B Price by Type (2023-2028) & (USD/Pcs)
Table 40. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2017-2022) & (K Pcs)
Table 41. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2023-2028) & (K Pcs)
Table 42. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2017-2022) & (USD Million)
Table 43. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2023-2028) & (USD Million)
Table 44. Global Human Cytomegalovirus Envelope Glycoprotein B Price by Application (2017-2022) & (USD/Pcs)
Table 45. Global Human Cytomegalovirus Envelope Glycoprotein B Price by Application (2023-2028) & (USD/Pcs)
Table 46. North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2017-2022) & (K Pcs)
Table 47. North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2023-2028) & (K Pcs)
Table 48. North America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2017-2022) & (USD Million)
Table 49. North America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2023-2028) & (USD Million)
Table 50. North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2017-2022) & (K Pcs)
Table 51. North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2023-2028) & (K Pcs)
Table 52. North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2017-2022) & (K Pcs)
Table 53. North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2023-2028) & (K Pcs)
Table 54. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2017-2022) & (K Pcs)
Table 55. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2023-2028) & (K Pcs)
Table 56. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2017-2022) & (USD Million)
Table 57. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2023-2028) & (USD Million)
Table 58. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2017-2022) & (K Pcs)
Table 59. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2023-2028) & (K Pcs)
Table 60. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2017-2022) & (K Pcs)
Table 61. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2023-2028) & (K Pcs)
Table 62. Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2017-2022) & (K Pcs)
Table 63. Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2023-2028) & (K Pcs)
Table 64. Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region (2017-2022) & (USD Million)
Table 65. Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region (2023-2028) & (USD Million)
Table 66. Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2017-2022) & (K Pcs)
Table 67. Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2023-2028) & (K Pcs)
Table 68. Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2017-2022) & (K Pcs)
Table 69. Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2023-2028) & (K Pcs)
Table 70. South America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2017-2022) & (K Pcs)
Table 71. South America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2023-2028) & (K Pcs)
Table 72. South America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2017-2022) & (USD Million)
Table 73. South America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2023-2028) & (USD Million)
Table 74. South America Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2017-2022) & (K Pcs)
Table 75. South America Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2023-2028) & (K Pcs)
Table 76. South America Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2017-2022) & (K Pcs)
Table 77. South America Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2023-2028) & (K Pcs)
Table 78. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2017-2022) & (K Pcs)
Table 79. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2023-2028) & (K Pcs)
Table 80. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region (2017-2022) & (USD Million)
Table 81. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region (2023-2028) & (USD Million)
Table 82. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2017-2022) & (K Pcs)
Table 83. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2023-2028) & (K Pcs)
Table 84. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2017-2022) & (K Pcs)
Table 85. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2023-2028) & (K Pcs)
Table 86. Human Cytomegalovirus Envelope Glycoprotein B Raw Material
Table 87. Key Manufacturers of Human Cytomegalovirus Envelope Glycoprotein B Raw Materials
Table 88. Direct Channel Pros & Cons
Table 89. Indirect Channel Pros & Cons
Table 90. Human Cytomegalovirus Envelope Glycoprotein B Typical Distributors
Table 91. Human Cytomegalovirus Envelope Glycoprotein B Typical Customers
List of Figures
Figure 1. Human Cytomegalovirus Envelope Glycoprotein B Picture
Figure 2. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Type in 2021
Figure 3. CSJ-148
Figure 4. CyMVectin
Figure 5. TRL-345
Figure 6. PPCM
Figure 7. Cytomegalovirus Vaccine
Figure 8. Others
Figure 9. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Application in 2021
Figure 10. Infectious Disease
Figure 11. Oncology
Figure 12. Women's Health
Figure 13. Others
Figure 14. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue, (USD Million) & (K Pcs): 2017 & 2021 & 2028
Figure 15. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue and Forecast (2017-2028) & (USD Million)
Figure 16. Global Human Cytomegalovirus Envelope Glycoprotein B Sales (2017-2028) & (K Pcs)
Figure 17. Global Human Cytomegalovirus Envelope Glycoprotein B Price (2017-2028) & (USD/Pcs)
Figure 18. Global Human Cytomegalovirus Envelope Glycoprotein B Production Capacity (2017-2028) & (K Pcs)
Figure 19. Global Human Cytomegalovirus Envelope Glycoprotein B Production Capacity by Geographic Region: 2022 VS 2028
Figure 20. Human Cytomegalovirus Envelope Glycoprotein B Market Drivers
Figure 21. Human Cytomegalovirus Envelope Glycoprotein B Market Restraints
Figure 22. Human Cytomegalovirus Envelope Glycoprotein B Market Trends
Figure 23. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Manufacturer in 2021
Figure 24. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Manufacturer in 2021
Figure 25. Human Cytomegalovirus Envelope Glycoprotein B Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 26. Top 3 Human Cytomegalovirus Envelope Glycoprotein B Manufacturer (Revenue) Market Share in 2021
Figure 27. Top 6 Human Cytomegalovirus Envelope Glycoprotein B Manufacturer (Revenue) Market Share in 2021
Figure 28. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region (2017-2028)
Figure 29. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Region (2017-2028)
Figure 30. North America Human Cytomegalovirus Envelope Glycoprotein B Revenue (2017-2028) & (USD Million)
Figure 31. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue (2017-2028) & (USD Million)
Figure 32. Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Revenue (2017-2028) & (USD Million)
Figure 33. South America Human Cytomegalovirus Envelope Glycoprotein B Revenue (2017-2028) & (USD Million)
Figure 34. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue (2017-2028) & (USD Million)
Figure 35. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2017-2028)
Figure 36. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Type (2017-2028)
Figure 37. Global Human Cytomegalovirus Envelope Glycoprotein B Price by Type (2017-2028) & (USD/Pcs)
Figure 38. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2017-2028)
Figure 39. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Application (2017-2028)
Figure 40. Global Human Cytomegalovirus Envelope Glycoprotein B Price by Application (2017-2028) & (USD/Pcs)
Figure 41. North America Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2017-2028)
Figure 42. North America Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2017-2028)
Figure 43. North America Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country (2017-2028)
Figure 44. North America Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country (2017-2028)
Figure 45. United States Human Cytomegalovirus Envelope Glycoprotein B Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Canada Human Cytomegalovirus Envelope Glycoprotein B Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. Mexico Human Cytomegalovirus Envelope Glycoprotein B Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2017-2028)
Figure 49. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2017-2028)
Figure 50. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country (2017-2028)
Figure 51. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country (2017-2028)
Figure 52. Germany Human Cytomegalovirus Envelope Glycoprotein B Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. France Human Cytomegalovirus Envelope Glycoprotein B Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. United Kingdom Human Cytomegalovirus Envelope Glycoprotein B Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Russia Human Cytomegalovirus Envelope Glycoprotein B Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Italy Human Cytomegalovirus Envelope Glycoprotein B Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2017-2028)
Figure 59. Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region (2017-2028)
Figure 60. Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Region (2017-2028)
Figure 61. China Human Cytomegalovirus Envelope Glycoprotein B Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Japan Human Cytomegalovirus Envelope Glycoprotein B Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Korea Human Cytomegalovirus Envelope Glycoprotein B Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. India Human Cytomegalovirus Envelope Glycoprotein B Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Southeast Asia Human Cytomegalovirus Envelope Glycoprotein B Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Australia Human Cytomegalovirus Envelope Glycoprotein B Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South America Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2017-2028)
Figure 68. South America Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2017-2028)
Figure 69. South America Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country (2017-2028)
Figure 70. South America Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country (2017-2028)
Figure 71. Brazil Human Cytomegalovirus Envelope Glycoprotein B Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Argentina Human Cytomegalovirus Envelope Glycoprotein B Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2017-2028)
Figure 74. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2017-2028)
Figure 75. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region (2017-2028)
Figure 76. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Region (2017-2028)
Figure 77. Turkey Human Cytomegalovirus Envelope Glycoprotein B Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Egypt Human Cytomegalovirus Envelope Glycoprotein B Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Saudi Arabia Human Cytomegalovirus Envelope Glycoprotein B Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. South Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Manufacturing Cost Structure Analysis of Human Cytomegalovirus Envelope Glycoprotein B in 2021
Figure 82. Manufacturing Process Analysis of Human Cytomegalovirus Envelope Glycoprotein B
Figure 83. Human Cytomegalovirus Envelope Glycoprotein B Industrial Chain
Figure 84. Sales Channel: Direct Channel vs Indirect Channel
Figure 85. Methodology
Figure 86. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
